Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes - PubMed (original) (raw)
Multicenter Study
Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes
Enrico Imbasciati et al. Am J Kidney Dis. 2007 Jun.
Abstract
Background: Prognostic criteria to inform women with moderate to severe renal insufficiency who wish to bear children are not well established.
Study design: Longitudinal multicenter cohort study.
Settings & participants: Nondiabetic white women with pregnancies proceeded beyond the 20th week and estimated glomerular filtration rate (GFR) less than 60 mL/min/1.73 m(2) (<1 mL/s/1.73 m(2)) before conception.
Predictors: Baseline GFR and proteinuria (exposure); other clinical characteristics at conception (covariates).
Outcomes & measurements: Difference in GFR decreases before conception versus after delivery (mixed linear models); low birth weight (<2,500 g), and maternal renal survival (logistic and Cox regressions).
Results: 49 women were studied. Mean serum creatinine and GFR at conception were 2.1 +/- 1 (SD) mg/dL (186 +/- 88 micromol/L) and 35 +/- 12 mL/min/1.73 m(2) (0.58 +/- 0.2 mL/s/1.73 m(2)), respectively. Overall mean GFR after delivery was less than before conception (30 +/- 13.8 versus 35 +/- 12.2 mL/min/1.73 m(2) [0.50 +/- 0.23 versus 0.58 +/- 0.20 mL/s/1.73 m(2)]; P < 0.001), but the rate of GFR decrease did not change (0.55 +/- 0.8 versus 0.50 +/- 0.3 mL/min/mo [0.0092 +/- 0.013 versus 0.0083 +/- 0.005 mL/s/mo]; P = 0.661). Independent of potential confounders, the combined presence of baseline GFR less than 40 mL/min/m(2) (<0.67 mL/s/m(2)) and proteinuria with protein greater than 1 g/d, but not either factor alone, predicted faster GFR loss after delivery compared with before conception (1.17 +/- 1.23 versus 0.55 +/- 0.39 mL/min/mo; difference, 0.62 mL/min/mo; 95% confidence interval [CI], 0.27 to 0.96 mL/min/mo [0.020 +/- 0.021 versus 0.0092 +/- 0.007 mL/s/mo; difference, 0.10 mL/s/mo; 95% CI, 0.005 to 0.016 mL/s/mo]). The presence of both risk factors, but not either alone, also predicted shorter time to dialysis therapy or GFR halving (N = 20; hazard ratio, 5.2; 95% CI, 1.7 to 15.9) and low birth weight (N = 29; odds ratio, 5.1; 95% CI, 1.03 to 25.6).
Limitations: Generalizability to other settings; study power.
Conclusion: In women with renal insufficiency, the presence of both GFR less than 40 mL/min/1.73 m(2) (<0.67 mL/s/m(2)) and proteinuria with protein greater than 1 g/d before conception predicts poor maternal and fetal outcomes.
Comment in
- Pregnancy and CKD: any progress?
Lindheimer MD, Davison JM. Lindheimer MD, et al. Am J Kidney Dis. 2007 Jun;49(6):729-31. doi: 10.1053/j.ajkd.2007.04.008. Am J Kidney Dis. 2007. PMID: 17533014 No abstract available.
Similar articles
- Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN. Anand IS, et al. Circulation. 2009 Oct 20;120(16):1577-84. doi: 10.1161/CIRCULATIONAHA.109.853648. Epub 2009 Oct 5. Circulation. 2009. PMID: 19805651 Clinical Trial. - Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
Perkins RM, Aboudara MC, Uy AL, Olson SW, Cushner HM, Yuan CM. Perkins RM, et al. Am J Kidney Dis. 2009 Apr;53(4):606-16. doi: 10.1053/j.ajkd.2008.11.026. Epub 2009 Feb 12. Am J Kidney Dis. 2009. PMID: 19216016 Clinical Trial. - Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
Ruggenenti P, Perna A, Mosconi L, Matalone M, Pisoni R, Gaspari F, Remuzzi G. Ruggenenti P, et al. Kidney Int Suppl. 1997 Dec;63:S54-7. Kidney Int Suppl. 1997. PMID: 9407422 Clinical Trial. - Chronic kidney disease and pregnancy: maternal and fetal outcomes.
Fischer MJ. Fischer MJ. Adv Chronic Kidney Dis. 2007 Apr;14(2):132-45. doi: 10.1053/j.ackd.2007.01.004. Adv Chronic Kidney Dis. 2007. PMID: 17395116 Review. - Chronic renal disease in pregnancy.
Ramin SM, Vidaeff AC, Yeomans ER, Gilstrap LC 3rd. Ramin SM, et al. Obstet Gynecol. 2006 Dec;108(6):1531-9. doi: 10.1097/01.AOG.0000246790.84218.44. Obstet Gynecol. 2006. PMID: 17138789 Review.
Cited by
- Maternal and Fetal Prognosis in Pregnant Women with Renal Disease Associating Urinary Tract Infection.
Meca DC, Cirstoiu MM. Meca DC, et al. Maedica (Bucur). 2024 Jun;19(2):260-266. doi: 10.26574/maedica.2024.19.2.2602024;. Maedica (Bucur). 2024. PMID: 39188840 Free PMC article. - Pregnancy in women with nephrotic-range proteinuria: A retrospective cohort study.
Svetitsky S, Lightstone L, Wiles K. Svetitsky S, et al. Obstet Med. 2024 Jun;17(2):96-100. doi: 10.1177/1753495X231201896. Epub 2023 Oct 9. Obstet Med. 2024. PMID: 38784182 - ORCHARD: a model for conducting pragmatic randomised trials in pregnancy.
Smith P, Dalrymple K, Clark K, Wang Y, Harris T, Webb AJ, Ashworth D, Chappell L, Bramham K. Smith P, et al. J Nephrol. 2024 Jun;37(5):1411-1413. doi: 10.1007/s40620-024-01952-5. Epub 2024 May 17. J Nephrol. 2024. PMID: 38760628 No abstract available. - Pre-gestational counselling for women living with CKD: starting from the bright side.
Da Silva I, Orozco-Guillén A, Longhitano E, Ballarin JA, Piccoli GB. Da Silva I, et al. Clin Kidney J. 2024 Mar 22;17(5):sfae084. doi: 10.1093/ckj/sfae084. eCollection 2024 May. Clin Kidney J. 2024. PMID: 38711748 Free PMC article. Review. - Pregnancy in Glomerular Disease: From Risk Identification to Counseling and Management.
Maressa V, Longhitano E, Casuscelli C, Di Carlo S, Peritore L, Santoro D. Maressa V, et al. J Clin Med. 2024 Mar 15;13(6):1693. doi: 10.3390/jcm13061693. J Clin Med. 2024. PMID: 38541918 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical